Detalhe da pesquisa
1.
Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myeloma.
Cancer
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38630908
2.
Single-agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM-2 trial.
Cancer
; 129(23): 3746-3760, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37622738
3.
Longer term outcomes with single-agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13-month follow-up from the pivotal DREAMM-2 study.
Cancer
; 127(22): 4198-4212, 2021 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34314018
4.
Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib.
Blood
; 133(7): 676-687, 2019 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30510081
5.
Belantamab mafodotin in combination with novel agents in relapsed/refractory multiple myeloma: DREAMM-5 study design.
Future Oncol
; 17(16): 1987-2003, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33682447
6.
Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study.
Lancet Oncol
; 21(2): 207-221, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31859245
7.
Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1.
Haematologica
; 105(10): 2440-2447, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054084
8.
Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial.
Lancet
; 385(9980): 1873-83, 2015 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25882396
9.
A phase 2, multicenter study investigating ofatumumab and bendamustine combination in patients with untreated or relapsed CLL.
Am J Hematol
; 91(9): 900-6, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27222473
10.
Health-related quality of life and patient-reported outcomes of ofatumumab plus chlorambucil versus chlorambucil monotherapy in the COMPLEMENT 1 trial of patients with previously untreated CLL.
Acta Oncol
; 55(9-10): 1115-1120, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27494089
11.
Ofatumumab maintenance versus observation in relapsed chronic lymphocytic leukaemia (PROLONG): an open-label, multicentre, randomised phase 3 study.
Lancet Oncol
; 16(13): 1370-9, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26377300
12.
Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patients.
Br J Haematol
; 170(1): 40-9, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25825041
13.
Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter study.
Blood
; 119(16): 3698-704, 2012 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-22389254
14.
Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemia.
Blood Adv
; 8(3): 591-602, 2024 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38052038
15.
A multicentre, phase II trial of ofatumumab monotherapy in relapsed/progressive diffuse large B-cell lymphoma.
Br J Haematol
; 163(3): 334-42, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24032456
16.
Ofatumumab is active in patients with fludarabine-refractory CLL irrespective of prior rituximab: results from the phase 2 international study.
Blood
; 118(19): 5126-9, 2011 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21856867
17.
Chemoimmunotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemia.
Blood
; 117(24): 6450-8, 2011 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-21498674
18.
Assessment of Periodontal Health Status among the Male Adult Population with a Dual Habit of Smoking and Gutkha Chewing: A Cross-Sectional Study.
J Pharm Bioallied Sci
; 15(Suppl 2): S1020-S1022, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37693974
19.
Effect of Commercially Available Nano-Hydroxyapatite Containing Desensitizing Toothpaste and Mouthwash on Dentinal Tubular Occlusion: A SEM Analysis.
J Pharm Bioallied Sci
; 15(Suppl 2): S1027-S1029, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37694094
20.
Safety, pharmacokinetics, and efficacy of belantamab mafodotin monotherapy in Japanese patients with relapsed or refractory multiple myeloma: DREAMM-11.
Int J Hematol
; 118(5): 596-608, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37668832